Jazz Pharmaceuticals Announces Third Quarter 2026 Financial Results

The Quick Take
– Broad commercial execution drives record quarterly revenues of $1.2 billion (+10% YoY) – – Company raises full year 2026 total revenue guidance – – Ziihera® launched in HER2+ 1L mGEA – – Xywav® revenues grew 12% YoY with 425 net patient adds in 3Q26 – – Closed Actio acquisition, adding...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
AAR prices offering of $955 million of 7.125% senior notes due 2031 and $960 million of 7.375% senior notes due 2034
WOOD DALE, Ill., Nov. 2, 2026 /PRNewswire/ -- AAR CORP. ("AAR" or the "Company") (NYSE: AIR), the leading parts, repair, and software platform in the aviation…
Business
MAA Announces Pricing of Senior Unsecured Notes Offering
GERMANTOWN, Tenn., Nov. 2, 2026 /PRNewswire/ -- Mid-America Apartment Communities, Inc., ("MAA") (NYSE: MAA) today announced that its operating partnership,…
Business
ネットアップ、PEAK:AIOの買収を完了し、ゼタバイト規模のAI導入を加速
カリフォルニア州サンノゼ--(BUSINESS WIRE)--(ビジネスワイヤ) --…
Business
Men's Clothing Experts Tom Napoli & Rico Marotto Discuss How to Choose Between a Suit & Tuxedo in HelloNation
The article explores how wedding dress codes, venues, and personal style influence the choice between suits and tuxedos. KEY HIGHLIGHTS A tuxedo is…
